✦ LIBER ✦

FC107 Interest of a computerized digital imaging system in the follow-up of pigmented lesions

✍ Scribed by J.A. Amaro; R.C. Sampaio

Book ID: 118604391
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 131 KB
Volume: 9
Category: Article
ISSN: 0926-9959
DOI: 10.1016/s0926-9959(97)89426-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter: Total Body Photography Versus Di

Letter: Total Body Photography Versus Digital Dermoscopic Follow-Up in the Diagnosis of Pigmented Lesions

✍ VINCENZO DE GIORGI; MARTA GRAZZINI; SUSANNA ROSSARI; ALESSIA GORI; FEDERICA SCAR 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Impact of digital dermoscopy analysis on

Impact of digital dermoscopy analysis on the decision to follow up or to excise a pigmented skin lesion: a multicentre study

✍ Marco Burroni; Uwe Wollina; Rocco Torricelli; Stefano Gilardi; Giordana Dell'Eva 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

(7) A new method for the quantification

(7) A new method for the quantification of physical change in unstable pigmented lesions using digital image processing techniques

✍ A.E. Murray; S.M. Neill; C.C. Harland; C.M.E. Rowland-Payne; R.C.D. Staughton; P 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Impact of dermoscopy and short-term sequ

Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial

✍ S.W. Menzies; J. Emery; M. Staples; S. Davies; B. McAvoy; J. Fletcher; K.R. Shah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

The radiological excision of high risk a

The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years

✍ Allen, S.D.; Osin, P.; Nerurkar, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB